Novo Nordisk Looks to Target Hair Loss in Consumer Push
The maker of Ozempic and Wegovy seeks to expand its direct-to-consumer pharmaceutical business as rival Eli Lilly outpaces in weight-loss drugs.
Beauty
Analysis and advice on the fast-evolving beauty business.
Merit Gets an Assist From Vasiliki Petrou
This week, Priya Rao gets into the makeup brand’s newest investor, dive into retail consolidation and look at Fenty Beauty foundation flares.
Halal Beauty’s World Leaders Struggle for Dominance
Indonesia has fallen from second to fourth place in the global halal beauty market, as local brands face consumer trust issues and international competition for Muslim shoppers.
The Next-Gen Makeup Artists Painting Beauty’s Future
These breakout beauty professionals may not yet be boldfaced names, but their work with era-defining celebrities and the world’s largest brands prove their influence is taking hold.
Beauty Enters Its ‘Superdupe’ Era
Mcobeauty’s newest launch, crafted with precisely the same formula as its pricier forebear, Urban Decay, showcases an evolving strategy for ‘dupe’ brands.
Human Skin Is the Newest Ingredient in K-Beauty
Skin boosters made from donated human tissue are booming at clinics across South Korea as patients seek new treatments to restore facial volume.
Beauty’s Favourite Celebrity Face: One That’s Not Everywhere
At a time when celebrities are expected to act like influencers, beauty companies are betting that underexposed talent can drive a bigger return on investment.
The BoF Podcast | Paloma Elsesser on Purpose, Representation and the New Rituals of Body Care
Paloma Elsesser joined The Business of Beauty’s executive editor Priya Rao about staying true to herself amid the pressures of tokenism and why — after a decade building other people’s brands — she’s finally thinking about building one of her own.
Exclusive: K18 Bets on Longevity
The hair care brand’s latest product, which will anchor a new longevity-focused franchise, plants a flag in what its founder calls one of the most consequential shifts beauty has ever seen.
Sephora Wants in on Serious Skincare. Medik8 Provides an Answer.
This week, we dive into the L’Oréal-owned skincare label’s cross-channel push and Estée Lauder’s collapsed sale news.
Is Blush’s Moment Fading?
Blush catapulted in sales growth over the past three years, earning its chops as a serious complexion product. Now it appears to be reaching a saturation point.
The Niche Retailers That Matter in Beauty
Premium brands often use niche retailers to signal their luxury positioning and reach discerning customers. But with high fixed costs and a smaller footprint than major retailers, not all are worth the investment.
For Some Patients, a Facelift Alone Isn’t Enough
'Pre-facelift' procedures like injectable biostimulators and radiofrequency are filling the gap between baby Botox jabs and hardcore deep plane surgeries. Beauty brands are getting in on the rush.
THE NEWS IN BRIEF
PR Agency CGC Launches Performance Media Division
Known for its premium beauty clients including Glossier and Hermès Beauty, the agency’s new division combines influencer marketing and AI insights.
Luxury Perfume Line Roja London Acquired by Extravaganza Beauty
Master perfumer and founder Roja Dove will remain with the brand in a new consultancy role.
Olaplex Names New CEO
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.
Perelel Expands C-Suite, Tapping Rare Beauty’s CMO
Known for its prenatal vitamins, the wellness label has hired Rare Beauty's Ashley Murphy as its chief marketing officer, while Anjelika Temple moves into the chief creative officer role.
Supergoop Announces Chief Commercial Officer
The sunscreen label has appointed former Coty executive Jamie Parker to the newly created role as it gears up to become a “global skin health company.”
L’Oréal Steals French Stock Market Crown From LVMH
The cosmetics group became France’s most valuable listed company on Tuesday, the first time since 2017 that a non-luxury company has claimed the top spot at the end of a trading day.
Kimberly-Clark Prepares Asset Sales to Win EU Nod for Kenvue Deal
The US consumer goods giant is preparing concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal, sources told Reuters.